Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
暂无分享,去创建一个
P. Dennis | M. Nau | S. Lipkowitz | A. Clark | M. Cuello | S. Ettenberg | M. Keane | R. Posner | S. Lipkowitz